We are live on ! Find out more
CLB icon

Core Laboratories

195 hedge funds and large institutions have $762M invested in Core Laboratories in 2025 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 56 increasing their positions, 77 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.33% more ownership

Funds ownership: 108.22%108.55% (+0.33%)

7% less funds holding

Funds holding: 209195 (-14)

13% less capital invested

Capital invested by funds: $880M → $762M (-$118M)

27% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 77

34% less call options, than puts

Call options by funds: $321K | Put options by funds: $487K

36% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 33

Holders
195
Holders Change
-14
Holders Change %
-6.7%
% of All Funds
2.61%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
56
Reduced
77
Closed
33
Calls
$321K
Puts
$487K
Net Calls
-$166K
Net Calls Change
-$263K
Name Holding Trade Value Shares
Change
Change in
Stake
AI
1
Ariel Investments
Illinois
$155M +$11.9M +709,455 +7%
BlackRock
2
BlackRock
New York
$113M -$6.91M -412,761 -5%
DGI
3
Disciplined Growth Investors
Minnesota
$82.3M -$200K -11,929 -0.2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$81.2M -$2.92M -174,600 -3%
EARNEST Partners
5
EARNEST Partners
Georgia
$54.4M -$911K -54,441 -1%
State Street
6
State Street
Massachusetts
$29M -$1.23M -73,375 -4%
T. Rowe Price Investment Management
7
T. Rowe Price Investment Management
Maryland
$16.5M -$1.01M -60,074 -5%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$16.2M +$385K +23,006 +2%
Fisher Asset Management
9
Fisher Asset Management
Washington
$15.2M +$1.18M +70,295 +7%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$14.6M +$2.09M +124,578 +15%
RA
11
Royce & Associates
New York
$14.6M +$34.5K +2,059 +0.2%
FAM
12
Fred Alger Management
New York
$11M +$3.02M +180,344 +32%
BTW
13
Boston Trust Walden
Massachusetts
$9.16M -$108K -6,447 -1%
Morgan Stanley
14
Morgan Stanley
New York
$8.84M -$5.11M -305,193 -34%
Northern Trust
15
Northern Trust
Illinois
$7.96M -$783K -46,767 -8%
Charles Schwab
16
Charles Schwab
California
$7.46M -$21.9K -1,309 -0.3%
GJL
17
Gendell Jeffrey L
$6.85M +$449K +26,835 +6%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$6.15M -$662K -39,567 -9%
Hotchkis & Wiley Capital Management
19
Hotchkis & Wiley Capital Management
California
$6.01M +$6.71M +400,790 New
VanEck Associates
20
VanEck Associates
New York
$5.92M -$812K -48,521 -11%
UBS Group
21
UBS Group
Switzerland
$5.65M -$4.15K -248 -0.1%
Envestnet Asset Management
22
Envestnet Asset Management
Illinois
$3.81M +$56.2K +3,357 +1%
ACM
23
Advisors Capital Management
New Jersey
$3.58M +$129K +7,718 +3%
Invesco
24
Invesco
Georgia
$3.51M -$309K -18,431 -7%
Principal Financial Group
25
Principal Financial Group
Iowa
$3.51M +$79.2K +4,733 +2%

CLB Hedge Fund Activity: Q1 2025 in Review

195 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2025, worth a combined $762M — down 13% from $880M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of CLB and 21 opened new positions — a net loss of 12 holders — while 77 trimmed existing stakes and 56 added.

The largest buyer was Ariel Investments, adding an estimated $11.9M. The largest seller was BlackRock, cutting an estimated $6.91M.

  • 195 institutional investors held Core Laboratories (CLB) as of Q1 2025, down from 209 in Q4 2024.
  • Funds reported $762M of Core Laboratories stock for Q1 2025, down 13% quarter-over-quarter.
  • 21 funds opened new Core Laboratories positions in Q1 2025 and 33 closed out, a net change of -12 holders.
  • The largest Core Laboratories buyer in Q1 2025 was Ariel Investments, an estimated $11.9M added.
  • The largest Core Laboratories seller in Q1 2025 was BlackRock, an estimated $6.91M sold.

Based on aggregated 13F filings for Q1 2025.